Quiroga Cortes Isidoro Alfonso 4
4 · Rani Therapeutics Holdings, Inc. · Filed Jan 3, 2023
Insider Transaction Report
Form 4
Quiroga Cortes Isidoro Alfonso
10% Owner
Transactions
- Purchase
Class A Common Stock
2022-12-30$6.03/sh+8,400$50,617→ 5,271,378 total(indirect: By Partnership)
Footnotes (2)
- [F1]The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.84 to $6.20 per share, inclusive. The reporting persons undertake to provide Rani Therapeutics Holdings, Inc., a Delaware corporation (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (1) to this Form 4.
- [F2]Isidoro Alfonso Quiroga Cortes directly owns 100% of the issued and outstanding interest of the Aequanimitas Management LLC (the "General Partner"). The General Partner directly controls Aequanimitas Limited Partnership ("Aequanimitas") as its general partner with the power to manage Aequanimitas. Quiroga Cortes is the sole limited partner of Aequanimitas.